Logo image of BMY

BRISTOL-MYERS SQUIBB CO (BMY) Stock Fundamental Analysis

USA - NYSE:BMY - US1101221083 - Common Stock

42.82 USD
-0.57 (-1.31%)
Last: 10/28/2025, 7:38:17 PM
42.89 USD
+0.07 (+0.16%)
After Hours: 10/28/2025, 7:38:17 PM
Fundamental Rating

6

Taking everything into account, BMY scores 6 out of 10 in our fundamental rating. BMY was compared to 192 industry peers in the Pharmaceuticals industry. BMY has an excellent profitability rating, but there are some minor concerns on its financial health. BMY may be a bit undervalued, certainly considering the very reasonable score on growth Finally BMY also has an excellent dividend rating. These ratings could make BMY a good candidate for value and dividend investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

BMY had positive earnings in the past year.
BMY had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BMY reported negative net income in multiple years.
Each year in the past 5 years BMY had a positive operating cash flow.
BMY Yearly Net Income VS EBIT VS OCF VS FCFBMY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B 15B

1.2 Ratios

The Return On Assets of BMY (5.33%) is better than 89.06% of its industry peers.
Looking at the Return On Equity, with a value of 28.96%, BMY belongs to the top of the industry, outperforming 95.31% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 16.93%, BMY belongs to the top of the industry, outperforming 94.27% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BMY is below the industry average of 15.41%.
The last Return On Invested Capital (16.93%) for BMY is above the 3 year average (12.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.33%
ROE 28.96%
ROIC 16.93%
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)12.3%
ROIC(5y)10.36%
BMY Yearly ROA, ROE, ROICBMY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

Looking at the Profit Margin, with a value of 10.58%, BMY belongs to the top of the industry, outperforming 86.46% of the companies in the same industry.
With an excellent Operating Margin value of 30.27%, BMY belongs to the best of the industry, outperforming 94.27% of the companies in the same industry.
In the last couple of years the Operating Margin of BMY has declined.
BMY's Gross Margin of 73.92% is amongst the best of the industry. BMY outperforms 80.73% of its industry peers.
In the last couple of years the Gross Margin of BMY has remained more or less at the same level.
Industry RankSector Rank
OM 30.27%
PM (TTM) 10.58%
GM 73.92%
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
BMY Yearly Profit, Operating, Gross MarginsBMY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BMY is creating value.
BMY has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, BMY has less shares outstanding
BMY has a worse debt/assets ratio than last year.
BMY Yearly Shares OutstandingBMY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
BMY Yearly Total Debt VS Total AssetsBMY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

BMY has an Altman-Z score of 2.00. This is not the best score and indicates that BMY is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.00, BMY is in the better half of the industry, outperforming 63.54% of the companies in the same industry.
BMY has a debt to FCF ratio of 3.37. This is a good value and a sign of high solvency as BMY would need 3.37 years to pay back of all of its debts.
The Debt to FCF ratio of BMY (3.37) is better than 88.54% of its industry peers.
BMY has a Debt/Equity ratio of 2.56. This is a high value indicating a heavy dependency on external financing.
BMY has a Debt to Equity ratio of 2.56. This is in the lower half of the industry: BMY underperforms 79.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.56
Debt/FCF 3.37
Altman-Z 2
ROIC/WACC2.09
WACC8.12%
BMY Yearly LT Debt VS Equity VS FCFBMY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

A Current Ratio of 1.21 indicates that BMY should not have too much problems paying its short term obligations.
BMY's Current ratio of 1.21 is on the low side compared to the rest of the industry. BMY is outperformed by 77.60% of its industry peers.
A Quick Ratio of 1.11 indicates that BMY should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.11, BMY is doing worse than 72.40% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 1.11
BMY Yearly Current Assets VS Current LiabilitesBMY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

5

3. Growth

3.1 Past

BMY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 391.24%, which is quite impressive.
The earnings per share for BMY have been decreasing by -24.57% on average. This is quite bad
The Revenue has been growing slightly by 2.57% in the past year.
The Revenue has been growing by 13.06% on average over the past years. This is quite good.
EPS 1Y (TTM)391.24%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-29.47%
Revenue 1Y (TTM)2.57%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%0.56%

3.2 Future

The Earnings Per Share is expected to grow by 36.11% on average over the next years. This is a very strong growth
BMY is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.99% yearly.
EPS Next Y467.96%
EPS Next 2Y131.17%
EPS Next 3Y73.61%
EPS Next 5Y36.11%
Revenue Next Year-1.07%
Revenue Next 2Y-4.7%
Revenue Next 3Y-3.54%
Revenue Next 5Y-4.99%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BMY Yearly Revenue VS EstimatesBMY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B
BMY Yearly EPS VS EstimatesBMY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

10

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 6.36, the valuation of BMY can be described as very cheap.
95.31% of the companies in the same industry are more expensive than BMY, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of BMY to the average of the S&P500 Index (26.83), we can say BMY is valued rather cheaply.
A Price/Forward Earnings ratio of 7.03 indicates a rather cheap valuation of BMY.
91.67% of the companies in the same industry are more expensive than BMY, based on the Price/Forward Earnings ratio.
BMY is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.88, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.36
Fwd PE 7.03
BMY Price Earnings VS Forward Price EarningsBMY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BMY's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BMY is cheaper than 95.83% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BMY is valued cheaper than 94.79% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.98
EV/EBITDA 5.86
BMY Per share dataBMY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of BMY may justify a higher PE ratio.
A more expensive valuation may be justified as BMY's earnings are expected to grow with 73.61% in the coming years.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y131.17%
EPS Next 3Y73.61%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.66%, BMY is a good candidate for dividend investing.
BMY's Dividend Yield is rather good when compared to the industry average which is at 6.29. BMY pays more dividend than 98.44% of the companies in the same industry.
BMY's Dividend Yield is rather good when compared to the S&P500 average which is at 2.30.
Industry RankSector Rank
Dividend Yield 5.66%

5.2 History

The dividend of BMY is nicely growing with an annual growth rate of 11.67%!
BMY has paid a dividend for at least 10 years, which is a reliable track record.
BMY has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)11.67%
Div Incr Years3
Div Non Decr Years3
BMY Yearly Dividends per shareBMY Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

98.12% of the earnings are spent on dividend by BMY. This is not a sustainable payout ratio.
BMY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP98.12%
EPS Next 2Y131.17%
EPS Next 3Y73.61%
BMY Yearly Income VS Free CF VS DividendBMY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B 15B
BMY Dividend Payout.BMY Dividend Payout, showing the Payout Ratio.BMY Dividend Payout.PayoutRetained Earnings

BRISTOL-MYERS SQUIBB CO

NYSE:BMY (10/28/2025, 7:38:17 PM)

After market: 42.89 +0.07 (+0.16%)

42.82

-0.57 (-1.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-30 2025-10-30/bmo
Inst Owners82.84%
Inst Owner Change0.03%
Ins Owners0.02%
Ins Owner Change-3.25%
Market Cap87.16B
Revenue(TTM)47.70B
Net Income(TTM)5.05B
Analysts67.27
Price Target52.62 (22.89%)
Short Float %1.49%
Short Ratio2.15
Dividend
Industry RankSector Rank
Dividend Yield 5.66%
Yearly Dividend2.42
Dividend Growth(5Y)11.67%
DP98.12%
Div Incr Years3
Div Non Decr Years3
Ex-Date10-03 2025-10-03 (0.62)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.2%
Min EPS beat(2)19.36%
Max EPS beat(2)35.04%
EPS beat(4)4
Avg EPS beat(4)21.86%
Min EPS beat(4)13.54%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)17.22%
EPS beat(12)11
Avg EPS beat(12)11.73%
EPS beat(16)15
Avg EPS beat(16)9.9%
Revenue beat(2)2
Avg Revenue beat(2)5.24%
Min Revenue beat(2)3.68%
Max Revenue beat(2)6.79%
Revenue beat(4)4
Avg Revenue beat(4)5.13%
Min Revenue beat(4)3.68%
Max Revenue beat(4)6.79%
Revenue beat(8)7
Avg Revenue beat(8)3.53%
Revenue beat(12)8
Avg Revenue beat(12)1.72%
Revenue beat(16)10
Avg Revenue beat(16)1.44%
PT rev (1m)0%
PT rev (3m)-4.98%
EPS NQ rev (1m)-8.17%
EPS NQ rev (3m)-8.34%
EPS NY rev (1m)-1.68%
EPS NY rev (3m)-2.69%
Revenue NQ rev (1m)0.43%
Revenue NQ rev (3m)1.53%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)2.32%
Valuation
Industry RankSector Rank
PE 6.36
Fwd PE 7.03
P/S 1.83
P/FCF 5.98
P/OCF 5.48
P/B 5
P/tB N/A
EV/EBITDA 5.86
EPS(TTM)6.73
EY15.72%
EPS(NY)6.09
Fwd EY14.23%
FCF(TTM)7.16
FCFY16.73%
OCF(TTM)7.81
OCFY18.24%
SpS23.44
BVpS8.57
TBVpS-12.64
PEG (NY)0.01
PEG (5Y)N/A
Graham Number36.01
Profitability
Industry RankSector Rank
ROA 5.33%
ROE 28.96%
ROCE 21.51%
ROIC 16.93%
ROICexc 21.21%
ROICexgc 107.32%
OM 30.27%
PM (TTM) 10.58%
GM 73.92%
FCFM 30.56%
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)12.3%
ROIC(5y)10.36%
ROICexc(3y)14.46%
ROICexc(5y)12.33%
ROICexgc(3y)78.95%
ROICexgc(5y)80.83%
ROCE(3y)15.62%
ROCE(5y)13.15%
ROICexgc growth 3Y-16.88%
ROICexgc growth 5Y3.18%
ROICexc growth 3Y7.41%
ROICexc growth 5Y19.82%
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 2.56
Debt/FCF 3.37
Debt/EBITDA 2.14
Cap/Depr 20.37%
Cap/Sales 2.77%
Interest Coverage 6.99
Cash Conversion 75.95%
Profit Quality 288.73%
Current Ratio 1.21
Quick Ratio 1.11
Altman-Z 2
F-Score7
WACC8.12%
ROIC/WACC2.09
Cap/Depr(3y)12.09%
Cap/Depr(5y)10.53%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)391.24%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-29.47%
EPS Next Y467.96%
EPS Next 2Y131.17%
EPS Next 3Y73.61%
EPS Next 5Y36.11%
Revenue 1Y (TTM)2.57%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%0.56%
Revenue Next Year-1.07%
Revenue Next 2Y-4.7%
Revenue Next 3Y-3.54%
Revenue Next 5Y-4.99%
EBIT growth 1Y30.41%
EBIT growth 3Y0.79%
EBIT growth 5Y8.21%
EBIT Next Year263.82%
EBIT Next 3Y49.42%
EBIT Next 5Y23.71%
FCF growth 1Y35.99%
FCF growth 3Y-2.91%
FCF growth 5Y14.03%
OCF growth 1Y34.19%
OCF growth 3Y-2.14%
OCF growth 5Y13.49%

BRISTOL-MYERS SQUIBB CO / BMY FAQ

Can you provide the ChartMill fundamental rating for BRISTOL-MYERS SQUIBB CO?

ChartMill assigns a fundamental rating of 6 / 10 to BMY.


What is the valuation status of BRISTOL-MYERS SQUIBB CO (BMY) stock?

ChartMill assigns a valuation rating of 10 / 10 to BRISTOL-MYERS SQUIBB CO (BMY). This can be considered as Undervalued.


What is the profitability of BMY stock?

BRISTOL-MYERS SQUIBB CO (BMY) has a profitability rating of 7 / 10.


What are the PE and PB ratios of BRISTOL-MYERS SQUIBB CO (BMY) stock?

The Price/Earnings (PE) ratio for BRISTOL-MYERS SQUIBB CO (BMY) is 6.36 and the Price/Book (PB) ratio is 5.


Can you provide the dividend sustainability for BMY stock?

The dividend rating of BRISTOL-MYERS SQUIBB CO (BMY) is 7 / 10 and the dividend payout ratio is 98.12%.